NASA Spaceline Current Awareness September 4, 2009
NASA Spaceline Current Awareness September 4, 2009
NASA Spaceline Current Awareness September 4, 2009
Read more on SpaceRef
Novelos Therapeutics Discontinues Current Development Program for NOV-002 in NSCLC
Novelos Therapeutics Discontinues Current Development Program for NOV-002 in NSCLC
NEWTON, Mass.—-Novelos Therapeutics, Inc. , a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that primary and secondary endpoints were not met in Novelos’ pivotal Phase 3 trial in advanced non-small cell lung cancer with its lead product, NOV-002, in combination with first-line chemotherapy.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Research Tags: current, Development, Discontinues, NOV002, Novelos, NSCLC, program, Therapeutics'
